CA9 and bone neoplasm: Nevertheless, given the relevance of intratumoural acidosis in bone cancers, the use of CAIX inhibitors, acid-targeted PDT strategies, or novel drugs that can safely and selectively impair the protumourigenic pathways that are selectively induced by extracellular acidosis may hold, for the future, helpful results to improve patient survival.